UBS has reiterated its Buy recommendation for Soitec while lowering its target price to €146 from €171, indicating a potential upside of 72%. The firm confirmed fiscal 2025 targets, expecting stable sales compared to 2023-2024 and an EBITDA margin of around 35%. However, capital expenditure forecasts have been slightly reduced to €230 million from €250 million.